Virus injection tested to fight breast cancer before surgery
NCT ID NCT07150767
Summary
This early-stage study aimed to test the safety and find the right dose of a new virus-based injection (BioTTT001) when given alongside standard pre-surgery treatment for locally advanced breast cancer. The trial planned to enroll women with non-metastatic breast cancer to receive the injection directly into their tumor. However, the study was withdrawn by the sponsor before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED BREAST CANCER (LABC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Second People's Hospital of Shandong Province
Jinan, Shandong, 250022, China
Conditions
Explore the condition pages connected to this study.